Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ChemAxon Major Software Release brings New Desktop, Web and Visualization Applications to Power Chemistry Decision Making

Published: Thursday, May 30, 2013
Last Updated: Thursday, May 30, 2013
Bookmark and Share
New version sets the standard in chemistry software for scientists and IT infrastructure.

ChemAxon announces Version 6 of their cheminformatics suite. This major software release introduces four new products:  Marvin for JavaScript, Instant JChem Web Client, REST Web Services, and the Plexus project, a public beta of a web-based discovery application for bench scientists. In addition, Version 6 sees a raft of enhancements across the ChemAxon Marvin/JChem product suite improving user experience, computational performance and collaboration support, and enabling more effective chemistry data management.

Version 6 for scientists:
•    All GUIs are refreshed to simplify both the user experience and access to key chemistry functions
•    Marvin for JavaScript - new light-weight chemical editor for web pages which does not require Java
•    Plexus - new web-based application for medicinal and computational chemists, featuring dynamic data visualization
•    Improved integration with Microsoft Office
 
Version 6 for enterprise IT:
•    Instant JChem Web Client - enables Instant JChem data visualization forms to be easily made available and worked with as Web pages
•    New REST Web Services to complement existing SOA Web Services
•    New search features and indexing support for ISIS and ChemDraw Excel workbooks in JChem for SharePoint
•    Enhanced compound registration capabilities, including project-related data storage
 
“Research-based organizations need to support increasingly diverse and distributed R&D environments,” commented Alex Drijver, CEO of ChemAxon. “The Version 6 release deepens our core chemistry and technical capabilities, and focuses on making that functionality more relevant to researchers’ processes with improved usability and new collaboration and analysis interfaces.”

ChemAxon software is adopted by a diverse customer base to support and accelerate the process from initial concept to new product candidate, minimizing IT overheads. The software suite offers robust, scalable and flexible chemistry information management that is easily aligned with organizations’ business processes. ChemAxon’s client base includes all of the top 15 global pharma companies, major chemical and agrochemistry companies, innovative biotechnology enterprises and academic research centres world-wide.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ChemAxon Provides Chemistry Informatics Platform for the European Lead Factory
ChemAxon will provide the core tools to support the pan European initiative.
Tuesday, June 18, 2013
ChemAxon Extends chemicalize.org Free Service with Predicted Data and User Customization
The new features help users understand better the chemical structure with more predicted properties and a customizable layout.
Monday, August 23, 2010
Broad Institute Acquires License to all ChemAxon Products and Deploys Across Chemical Biology Platform
License covers ChemAxon’s platform, discovery toolkits and desktop applications for institute-wide use.
Friday, August 20, 2010
ChemAxon Announces new CEO and Head of R&D
Company increases its focus on business development and market position with new appointments.
Tuesday, May 13, 2008
Migrating Chemical Information to New Architectures
New ChemAxon whitepaper discusses the drivers behind the increasing number of pharma and biotech companies moving from traditional proprietary chemical information systems to modern alternatives.
Monday, January 29, 2007
Scientific News
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!